NovoCure Limited

NVCR

$11.30

Name : NovoCure Limited

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $1,285,876,736.00

EPSttm : -1.22

NovoCure Limited

$11.30

5.41%

$0.58

NVCR — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

8.84

Margin Of Safety %

Put/Call OI Ratio

0.36

EPS Next Q Diff

-0.15

EPS Last/This Y

-0.32

EPS This/Next Y

0.37

Price

10.72

Target Price

25.07

Analyst Recom

1.5

Performance Q

-25.3

Upside

-498.3%

Beta

0.61

Ticker: NVCR

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	NVCR	12.35	0.49	2.00	46503
2026-03-18	NVCR	12.07	0.50	1.82	47562
2026-03-19	NVCR	12.14	0.50	1.75	48182
2026-03-20	NVCR	11.81	0.53	3.82	49196
2026-03-23	NVCR	11.8	0.29	0.47	26100
2026-03-24	NVCR	11.36	0.31	0.46	27438
2026-03-25	NVCR	11.6	0.31	1.09	28565
2026-03-26	NVCR	11.77	0.34	0.90	30241
2026-03-27	NVCR	10.98	0.35	0.08	30672
2026-03-30	NVCR	10.37	0.35	0.29	30892
2026-03-31	NVCR	10.9	0.35	1.93	31034
2026-04-01	NVCR	10.84	0.35	0.06	31264
2026-04-02	NVCR	10.54	0.35	0.63	31356
2026-04-06	NVCR	10.54	0.35	0.45	31426
2026-04-08	NVCR	10.8	0.35	0.02	32037
2026-04-09	NVCR	11	0.35	1.26	32500
2026-04-13	NVCR	10.73	0.36	0.71	33166
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	NVCR	12.35	-57.1	-15.0	-1.51
2026-03-18	NVCR	12.08	-57.1	-12.0	-1.51
2026-03-19	NVCR	12.14	-57.1	-16.4	-1.51
2026-03-20	NVCR	11.81	-57.1	-11.1	-1.51
2026-03-23	NVCR	11.80	-57.1	-15.2	-1.51
2026-03-24	NVCR	11.36	-57.1	-9.3	-1.51
2026-03-25	NVCR	11.60	-57.1	-18.5	-1.51
2026-03-26	NVCR	11.76	-57.1	-17.4	-1.51
2026-03-27	NVCR	10.99	-57.1	-5.0	-1.51
2026-03-30	NVCR	10.36	-65.4	-6.4	-1.54
2026-03-31	NVCR	10.90	-65.4	-23.7	-1.54
2026-04-01	NVCR	10.84	-65.4	-14.3	-1.54
2026-04-02	NVCR	10.55	-65.4	-11.1	-1.54
2026-04-06	NVCR	10.54	-65.4	-15.2	-1.54
2026-04-07	NVCR	10.36	-65.4	-12.6	-1.54
2026-04-09	NVCR	11.00	-65.4	-18.4	-1.54
2026-04-10	NVCR	10.59	-65.4	-9.4	-1.54
2026-04-13	NVCR	10.72	-65.4	-17.4	-1.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	NVCR	-1.33	5.24	8.91
2026-03-18	NVCR	-1.33	5.24	8.91
2026-03-19	NVCR	-1.33	5.24	8.91
2026-03-20	NVCR	-1.33	5.24	8.91
2026-03-23	NVCR	-1.33	5.22	8.91
2026-03-24	NVCR	-1.33	5.22	8.91
2026-03-25	NVCR	-1.33	5.22	8.32
2026-03-26	NVCR	-1.33	5.22	8.32
2026-03-27	NVCR	-1.33	5.22	8.32
2026-03-30	NVCR	-1.33	5.22	8.32
2026-03-31	NVCR	-1.33	5.22	8.32
2026-04-01	NVCR	-1.33	5.22	8.32
2026-04-02	NVCR	-1.33	5.22	8.32
2026-04-06	NVCR	-1.33	5.23	8.32
2026-04-07	NVCR	-1.33	5.23	8.32
2026-04-08	NVCR	-1.33	5.23	8.32
2026-04-09	NVCR	-1.33	5.23	8.32
2026-04-10	NVCR	-1.33	5.23	8.32
2026-04-13	NVCR	-1.33	5.21	8.84
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.22

Avg. EPS Est. Current Quarter

-0.51

Avg. EPS Est. Next Quarter

-0.37

Insider Transactions

-1.33

Institutional Transactions

5.21

Beta

0.61

Average Sales Estimate Current Quarter

167

Average Sales Estimate Next Quarter

170

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.4

Max Drawdown 5-Year %

-95.6

Target Price

25.07

P/E

Forward P/E

PEG

P/S

1.86

P/B

3.54

P/Free Cash Flow

EPS

-1.22

Average EPS Est. Cur. Y

-1.54

EPS Next Y. (Est.)

-1.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-20.79

Relative Volume

0.41

Return on Equity vs Sector %

-67.3

Return on Equity vs Industry %

-51.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

-17.4

◆ NVCR Healthcare

$10.72

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

19/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

6/10

RSI

42.4

Range 1M

22.2%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

18/30

Estimates

2/20

Inst/Vol

5/15

Options

8/10

EPS Yr

-25.9%

EPS NY

24.1%

52W%

8.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +133.9% upside

Quality

6/30

Valuation

16/30

Growth

13/25

Stability

7/10

LT Trend

2/5

Upside

+133.9%

Quality

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1605

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

NVCR

Latest News

—

Caricamento notizie per NVCR…

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y